Cifrazol
NDC Package 69336-310-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cifrazol is  is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels, Vitamin D deficiency or are in need of Vitamin D supplementation and other nutritional supplementation. Marketed by Sterling Knight Pharmaceuticals,llc, this product is identified by NDC 69336-310.

Identification & Billing

NDC Package Code
69336-310-30
Package Description
30 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
69336-310
11-Digit Billing Format
69336031030
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk
  • RxCUI: 1593744 - vitamin D3 94.3 MCG (3775 UNT) / folate 1666 MCG DFE (1 MG folic acid) Oral Tablet
  • RxCUI: 1593744 - cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule
  • RxCUI: 1593744 - Cholecalciferol 3775 UNT / folate 1 MG Oral Capsule
  • RxCUI: 1593744 - cholecalciferol 94.38 MCG / folic acid 1 MG Oral Capsule
  • RxCUI: 1593744 - vitamin D3 94.3 MCG (3775 UNT) / folate 1666 MCG DFE (1 mg folic acid) Oral Tablet

Clinical Specifications

Proprietary Name
Cifrazol
Dosage Form
-
Usage Information
Cifrazol is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels, Vitamin D deficiency or are in need of Vitamin D supplementation and other nutritional supplementation.

Regulatory & Marketing

Labeler Name
Sterling Knight Pharmaceuticals,llc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-10-2017
End Marketing Date
12-01-2020
Listing Expiration
12-01-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69336-310-30 identifies a specific commercial package of 30 capsule in 1 bottle, plastic of Cifrazol, labeled by Sterling Knight Pharmaceuticals,llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sterling Knight Pharmaceuticals,llc on January 10, 2017. The current certification is valid through December 01, 2020.

How is this Sterling Knight Pharmaceuticals,llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69336031030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69336-310-30
11-Digit CMS (5-4-2)
69336-0310-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.